Molecular Assay for Drug Resistant TB Testing
Solicitation number tender_18543
Publication date
Closing date and time 2024/05/21 11:00 EDT
Last amendment date
Description
Vendor: Becton Dickinson Canada Inc
Product: BD Max MDR-TB Assay
Purpose: A Health Canada approved assay for the detection of drug resistant Mycobacterium tuberculosis. The drug resistance targets sought as part of this assay are for isoniazid and rifampin.
PHO has a requirement a commercial Health Canada approved molecular assay for detection of drug resistant Mycobacterium tuberculosis, with drug resistance targets of isoniazid and rifampin. Recent changes to the Canadian Tuberculosis Standards require a test with a short turnaround time to determine prompt treatment for individuals with M. tuberculosis detected by molecular assays. As such, PHO requires supply of an assay which is capable of detecting multidrug resistant tuberculosis from clinical specimens, as well as culture isolates.
PHO believes that the BD MAX MDR-TB Assay is the only commercial Health Canada approved assay for this use capable of detecting isoniazid and rifampin resistant M. tuberculosis.
PHO intends to award a 5 year term contract (comprised of 2 firm years and 3 one-year options) to Becton Dickinson for the products described above.
This request does not constitute a call for tenders.
Contract duration
The estimated contract period will be 24 month(s).
Trade agreements
-
World Trade Organization Agreement on Government Procurement (WTO GPA)
-
Canadian Free Trade Agreement (CFTA)
-
Canada-European Union Comprehensive Economic and Trade Agreement (CETA)
-
Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP)
-
Canada-UK Trade Continuity Agreement (Canada-UK TCA)
Partner with another business
The functionality to add your company name to the list of interested businesses is temporarily unavailable.
This list does not replace or affect the tendering procedures for this procurement process. Businesses are still required to respond to bid solicitations, and to compete based on the set criteria. For more information please read the Terms of use.
Contact information
Contracting organization
- Organization
-
Public Health Ontario
- Address
-
480 University Avenue, Suite 300Toronto, Ontario, M5G1V2Canada
- Contracting authority
- Jonathon Martynski
- Phone
- 647-260-7308
- Email
- jonathon.martynski@oahpp.ca
- Address
-
647-260-7308
Bidding details
Full details for this tender opportunity are available on a third-party site
Click on the button below to be directed to this website. Note that on the third-party site you may need an account to view and/or bid on this tender. Information on any fees or additional costs to access the full details is outlined in the Description tab of this tender opportunity.
Eligibility and terms and conditions
Government of Canada tender and awards notices, solicitation documents, and other attachments are fully accessible and available free of charge and without having to register on CanadaBuys.
Information may be available on another source prior to being available on CanadaBuys. You may have received this information through a third-party distributor. The Government of Canada is not responsible for any tender notices and/or related documents and attachments not accessed directly from CanadaBuys.canada.ca.
Government of Canada tender or award notices carry an OpenGovernment License - Canada that governs its use. Related solicitation documents and/or tender attachments are copyright protected. Please refer to our terms and conditions page for more information.
